Publications by authors named "Guilherme Rabinowits"

41Publications

Outcomes following radiation for cutaneous squamous cell carcinoma of the head and neck: Associations between immune suppression and recurrence.

Head Neck 2019 07 29;41(7):2111-2115. Epub 2019 Jan 29.

Department of Radiation Oncology, Dana-Farber/ Brigham and Women's Cancer Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.25663DOI Listing
July 2019

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.

N Engl J Med 2018 07 4;379(4):341-351. Epub 2018 Jun 4.

From the Departments of Dermatology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston (M.R.M.), and South Texas Accelerated Research Therapeutics (START), San Antonio (K.P.P.) - both in Texas; the Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (D.R., A.A.T.), the Department of Medical Oncology, Royal North Shore Hospital, St. Leonards, VIC (A.G.), the Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA (A.M.L.), and Royal Brisbane and Women's Hospital and University of Queensland, Brisbane (B.G.M.H.) - all in Australia; the Department of Dermatology, Brigham and Women's Hospital (C.D.S.), the Department of Dermatology, Harvard Medical School (C.D.S.), and the Department of Medical Oncology, Dana-Farber Cancer Institute (G.R.) - all in Boston; Schleswig-Holstein University Hospital, Kiel (A.H.), and University Hospital Essen, Essen and German Cancer Consortium, Essen (D.S.) - both in Germany; University of Colorado Denver, School of Medicine, Aurora (K.D.L.); the Departments of Head and Neck-Endocrine Oncology (C.H.C.) and Cutaneous Oncology (N.I.K.), H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; the Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St. Louis (L.H.-A.); the Department of Dermatology, Stanford University School of Medicine, Redwood City (A.L.S.C.), and the Division of Dermatology, City of Hope, Duarte (B.M.) - both in California; the Department of Medicine, Head and Neck Medical Oncology, Memorial Sloan Kettering Cancer Center, New York (L.A.D.), and Regeneron Pharmaceuticals, Tarrytown (F.S., M.M., K.M., G.D.Y., I.L., M.G.F.) - both in New York; Regeneron Pharmaceuticals, Basking Ridge, NJ (B.G., S.L., J.L., J.B., E.S.); University of Arizona Cancer Center, Tucson (H.M.B.), and Banner MD Anderson Cancer (J.H.) and the Department of Medical Oncology, Banner MD Anderson Cancer Center (J.N.), Gilbert - all in Arizona; Medical Oncology Department, Vall D'Hebron University Hospital (I.B.), and Institut Català D'Oncologia, Oncobell Program (IDIBELL), L'Hospitalet de Llobregat (M.G.-M.), Barcelona, and START Madrid-FJD, Hospital Fundación Jiménez Díaz, Madrid (V.M.) - all in Spain; Sarah Cannon Research Institute, Nashville (M.L.J.); and the Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta (T.K.O.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1805131
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1805131DOI Listing
July 2018

A case of Graves' ophthalmopathy associated with pembrolizumab (Keytruda) therapy.

J AAPOS 2018 08 4;22(4):310-312. Epub 2018 Apr 4.

Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaapos.2018.01.006DOI Listing
August 2018

Consider Surgery, but Not in This Case.

Int J Radiat Oncol Biol Phys 2018 01;100(1):16

Center for Cutaneous Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.08.032DOI Listing
January 2018

Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Cancer Discov 2018 02 3;8(2):196-215. Epub 2017 Nov 3.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-17-0833DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809290PMC
February 2018

Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?

Onco Targets Ther 2017 28;10:4803-4807. Epub 2017 Sep 28.

Department of Medical Oncology, Center for Head and Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S126640DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628662PMC
September 2017

Successful Management of a Patient with Malignant Thyroid Teratoma.

Thyroid 2017 01 28;27(1):125-128. Epub 2016 Nov 28.

4 Department of Otolaryngology, Brigham and Women's Hospital , Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2016.0201DOI Listing
January 2017

Merkel Cell Carcinoma: A Population Analysis on Survival.

J Natl Compr Canc Netw 2016 10;14(10):1247-1257

From Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School; Department of Radiation Oncology, and Department of Medical Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute; and Merkel Cell Carcinoma Clinic, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0134DOI Listing
October 2016

Merkel Cell Carcinoma Presenting as Subcutaneous Breast Masses: An Uncommon Presentation of a Rare Neuroendocrine Neoplasm.

Breast J 2016 Jan-Feb;22(1):113-5. Epub 2015 Nov 25.

Department of Dermatology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12534DOI Listing
October 2016

Optimizing Tobacco Cessation Resource Awareness Among Patients and Providers.

J Oncol Pract 2016 Jan 1;12(1):e77-82. Epub 2015 Sep 1.

Dana-Farber Cancer Institute; and Brigham and Women's Hospital, Boston, MA

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.2015.005124
Publisher Site
http://dx.doi.org/10.1200/JOP.2015.005124DOI Listing
January 2016

Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options.

Curr Treat Options Oncol 2014 Dec;15(4):595-610

Center for Head and Neck Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, 02215, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-014-0309-1
Publisher Site
http://dx.doi.org/10.1007/s11864-014-0309-1DOI Listing
December 2014

Update on the biology and clinical management of Merkel cell carcinoma.

Am Soc Clin Oncol Educ Book 2014 :e405-10

From the Department of Dermatology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA; Department of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.e405DOI Listing
December 2015

Systemic Therapy for Merkel Cell Carcinoma: What's on the Horizon?

Cancers (Basel) 2014 May 16;6(2):1180-94. Epub 2014 May 16.

Dana-Farber Cancer Institute, Harvard Medical School, Department of Medical Oncology, Center for Head and Neck Oncology, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers6021180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074823PMC
May 2014

In-hospital and long-term outcomes after percutaneous endoscopic gastrostomy in patients with malignancy.

J Am Coll Surg 2012 Dec 19;215(6):777-86. Epub 2012 Sep 19.

Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2012.08.013DOI Listing
December 2012

Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literature.

Oral Oncol 2012 Nov 25;48(11):1085-9. Epub 2012 Jul 25.

Dana-Farber Cancer Institute, 450 Brookline Ave. SW430, Boston, MA 02215, United States.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13688375120021
Publisher Site
http://dx.doi.org/10.1016/j.oraloncology.2012.06.016DOI Listing
November 2012

Fixed-dose every-other-week capecitabine and oxaliplatin for refractory squamous cell carcinoma of the head and neck.

Am J Med Sci 2010 Feb;339(2):148-51

Department of Medicine, J.G. Brown Cancer Center, University of Louisville, Kentucky 40202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAJ.0b013e3181c4bd91DOI Listing
February 2010

Bladder cancer: clinical practice.

J Ky Med Assoc 2009 Apr;107(4):129-33

University of Louisville, J. G. Brown Cancer Center, 529 South Jackson Street, Louisville, KY 40202, USA.

View Article

Download full-text PDF

Source
April 2009

Exosomal microRNA: a diagnostic marker for lung cancer.

Clin Lung Cancer 2009 Jan;10(1):42-6

J.G. Brown Cancer Center, University of Louisville, KY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2009.n.006DOI Listing
January 2009

Indolent course of thymic carcinoid.

J Clin Oncol 2007 Mar;25(9):1138-9

University of Louisville, J.G. Brown Cancer Center, Louisville, KY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.09.8855DOI Listing
March 2007